Posted On: 12/08/2016 11:04:18 AM
Post# of 18866
About Entest BioMedical, Inc. ~ $ENTB
Zander Therapeutics, Inc. is a veterinary biotechnology company that is wholly owned by Entest BioMedical, Inc.
Zander is primarily focused on developing small molecule therapies for treating autoimmune disorders and canine cancer (dogs).
Currently the Company is developing products treating blood disorders using small molecules based on NR2F6 under an exclusive license agreement for veterinary use.
Learn more at: http://zandertherapeutics.weebly.com
Zander Therapeutics, Inc. is a veterinary biotechnology company that is wholly owned by Entest BioMedical, Inc.
Zander is primarily focused on developing small molecule therapies for treating autoimmune disorders and canine cancer (dogs).
Currently the Company is developing products treating blood disorders using small molecules based on NR2F6 under an exclusive license agreement for veterinary use.
Learn more at: http://zandertherapeutics.weebly.com
(0)
(0)
